Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer
نویسندگان
چکیده
منابع مشابه
Epididymo-orchitis following intravesical bacillus Calmette-Guérin therapy.
OBJECTIVE To describe a case of epididymo-orchitis that developed four years after treatment with intravesical bacillus Calmette-Guérin (BCG) and to review the incidence of this adverse effect. DATA SOURCES Information about the patient was obtained from the medical chart. A MEDLINE search of English-language literature (from January 1976 to April 1999) was conducted. STUDY SELECTION All ca...
متن کاملManaging the adverse events of intravesical bacillus Calmette-Guérin therapy.
This paper provides recommendations on the management of complications arising from intravesical treatment with bacillus Calmette-Guérin (BCG) for nonmuscle-invasive bladder tumors. There is minimal recommendations currently available as randomized trials on the side effects of intravesical BCG are lacking and severe complications are usually described in case reports only. All physicians givin...
متن کاملIs Intravesical Bacillus Calmette-Guérin Therapy Superior to Chemotherapy for Intermediate-risk Non-muscle-invasive Bladder Cancer?: An Ongoing Debate
The objective of this study was to evaluate the risk of recurrence in patients with intermediate-risk non-muscle-invasive bladder cancer (NMIBC) after intravesical instillation with chemotherapeutic agents or Bacillus Calmette-Guérin (BCG) therapy. A cohort of 746 patients with intermediate-risk NMIBC comprised the study group. The primary outcome was time to first recurrence. The recurrence ra...
متن کاملThirty-five years of intravesical bacillus Calmette-Guérin for bladder cancer: where now?
It is 35 yr since Morales described the use of intravesical bacillus Calmette-Guérin (BCG) for non–muscle invasive bladder cancer (BC). In the interveningyearswehave learned much about this treatment. Although BCG is one of the most studied medicines in urology, many questions regarding its use remain [1]. In this month’s European Urology, Herr et al report their use of induction BCG for high-r...
متن کامل[Acute arthritis secondary to intravesical bacillus Calmette-Guérin for bladder cancer].
INTRODUCTION We sought to identify the prevalence, presentation, treatment, and prognosis of acute arthritis secondary to intravesical bacilli Calmette-Guérin (BCG) therapy for bladder cancer. METHODS We performed a structured, systematic review of the English language literature pertaining to BCG and reactive arthritis among bladder cancer patients. We extracted data pertaining to prevalence...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2017
ISSN: 1465-1858
DOI: 10.1002/14651858.cd012112.pub2